Browse Items (11 total)
- Tags: Randomized Controlled Trials as Topic
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Tags: 2019, Administration Intravenous, Adult, Aged, Anti-Bacterial Agents/administration & dosage/adverse effects/therapeutic use, antibiotic, Clinical Infectious Diseases, Das A, Diterpenes/administration & dosage/adverse effects/therapeutic use, Double-Blind Method, Female, File TM, Gasink LB, Gelone SP, Goldberg L, Hospital List, Humans, journalArticle, lefamulin, Linezolid/adverse effects/therapeutic use, Male, Microbial Sensitivity Tests, Middle Aged, Moxifloxacin, Moxifloxacin/administration & dosage/adverse effects/therapeutic use, Paukner S, pleuromutilin, Pneumonia, Pneumonia Bacterial/drug therapy/metabolism, Polycyclic Compounds/administration & dosage/adverse effects/therapeutic use, Randomized Controlled Trials as Topic, Saviski J, Seltzer E, Sweeney C, Talbot GH, Thioglycolates/administration & dosage/adverse effects/therapeutic use, Wicha WW
Tags: 2019, Abbott JD, Aged, Angioplasty Balloon Coronary/adverse effects/instrumentation/mortality, Brilakis ES, Cardiac Catheters, Cardiovascular Agents/administration & dosage/adverse effects, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, Cleveland Clinic Akron General Hospital, Coated Materials Biocompatible, Coronary Artery Disease/diagnostic imaging/mortality/therapy, Coronary Restenosis/epidemiology, Department of Internal Medicine, drug-coated balloons, drug-eluting balloons, Drug-Eluting Stents, Female, Humans, journalArticle, June2020SubmittedList, Kalra A, Kohl LP, Male, Megaly M, Middle Aged, NEOMED College of Medicine, Observational Studies as Topic, Randomized Controlled Trials as Topic, Rezq A, Risk Assessment, Risk Factors, Rofael M, Saad M, Shishehbor M, small-vessel disease coronary disease, Soukas P, Treatment Outcome
Tags: *Antineoplastic Combined Chemotherapy Protocols, 2003, Adjuvant – Methods, Biological Markers, Biopsy, Breast Neoplasms – Drug Therapy, Breast Neoplasms – Radiotherapy, Breast Neoplasms – Surgery, Breast Neoplasms/*drug therapy/*surgery, Chemotherapy, Clinical breast cancer, Clinical Trials, Europe, Evidence-Based Medicine, Female, Humans, Mamounas Eleftherios P, Neoadjuvant Therapy/*methods/*standards, Neoplasm Staging/methods, Polymerase Chain Reaction, Randomized Controlled Trials as Topic, Sentinel Lymph Node Biopsy/methods, Time Factors
Tags: *Diabetes Complications, *Onychomycosis/diagnosis/drug therapy/physiopathology, *Tinea Pedis/diagnosis/drug therapy/physiopathology, 2004, Aged, Antifungal Agents/adverse effects/pharmacokinetics/*therapeutic use, Arthrodermataceae/*pathogenicity, Biological Availability, Diabetes Mellitus/drug therapy, Drug Interactions, Drugs & aging, Humans, Hypoglycemic Agents/therapeutic use, Joseph Warren S, Metabolic Clearance Rate, Randomized Controlled Trials as Topic, Tan James S
Tags: 2015, Anti-Bacterial Agents/*therapeutic use, beta-Lactam Resistance/genetics, carbapenem-resistant Klebsiella pneumoniae, Carbapenems/*therapeutic use, combination antibiotic therapy, Combination/*statistics & numerical data, Department of Internal Medicine, Deresinski Stan, Drug Therapy, Expert review of anti-infective therapy, Humans, Klebsiella Infections/*drug therapy/microbiology, Klebsiella pneumoniae/*drug effects/genetics/pathogenicity, NEOMED College of Medicine, Randomized Controlled Trials as Topic, Watkins Richard R
Tags: *Bandages, 2018, Adult, Aged, American journal of clinical oncology, Arthur Douglas, Breast Neoplasms/*complications/pathology/*surgery, Cohort Studies, Combined Modality Therapy, Drainage/methods, Female, Grobmyer Stephen, Humans, Lymphedema/etiology/physiopathology/*therapy, Massage/methods, Mastectomy/*adverse effects/methods, Middle Aged, Prognosis, Quality of Life, Randomized Controlled Trials as Topic, Retrospective Studies, Risk Assessment, Schwarz Graham, Severity of Illness Index, Shah Chirag, Smile Timothy D, Survivors, Tendulkar Rahul, Treatment Outcome, Valente Stephanie, Vicini Frank
The effect of race on outcomes of surgical or nonsurgical treatment of patients in the Spine Patient Outcomes Research Trial (SPORT).
Tags: 2012, Adult, African Americans/statistics & numerical data, Aged, Bono Christopher M, Chi-Square Distribution, Disability Evaluation, European Continental Ancestry Group/statistics & numerical data, Female, Humans, Lurie Jon D, Male, Middle Aged, Outcome Assessment (Health Care)/*statistics & numerical data, Randomized Controlled Trials as Topic, Recovery of Function, Retrospective Studies, Schoenfeld Andrew J, Spinal Diseases/*ethnology/*surgery/therapy, Spine, Spine/pathology/physiopathology/*surgery, Surveys and Questionnaires, Zhao Wenyan
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
Tags: 2016, Anti-Bacterial Agents/*therapeutic use, Bacterial/*drug therapy, Ceftriaxone/*therapeutic use, Cephalosporins/*therapeutic use, Community-Acquired Infections/*drug therapy, Department of Internal Medicine, File Thomas M, Friedland H David, Humans, Iaconis Joseph P, Llorens Lily, Melnick David, NEOMED College of Medicine, Pneumonia, Randomized Controlled Trials as Topic, Sun Fang, Taboada Maria, The Journal of antimicrobial chemotherapy, Wilson David, Zhong Nan Shan
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Tags: 1999, Adult, American journal of kidney diseases : the official journal of the National Kidney Foundation, Angiotensin-Converting Enzyme Inhibitors/*therapeutic use, Antihypertensive Agents/*therapeutic use, Bain R P, Blood Pressure/drug effects, Blumenthal S, Captopril/*therapeutic use, Cattran D, Chronic/etiology, Creatinine/blood, Department of Internal Medicine, Diabetes Mellitus, Diabetic Nephropathies/*drug therapy/physiopathology, Disease Progression, Female, Follow-Up Studies, Hebert L A, Humans, Kidney Failure, Levey A S, Lewis E J, Lewis J B, Male, Middle Aged, NEOMED College of Medicine, Nephrotic Syndrome/complications/*drug therapy/physiopathology, Prospective Studies, Proteinuria, Randomized Controlled Trials as Topic, Remission Induction, Rohde R D, Spitalewitz S, Type 1/*complications, Whittier F, Wilmer W A
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Tags: 2017, 80 and over, Adult, Aged, Anti-Bacterial Agents/adverse effects/*therapeutic use, Atypical pathogen, Bacterial/*drug therapy, Ceftaroline fosamil, Ceftriaxone/adverse effects/*therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Chlamydial Pneumonia, Chlamydophila pneumoniae, Clinical Trials, Combination/adverse effects/methods, Community-Acquired Infections/*drug therapy, Community-acquired pneumonia, Department of Internal Medicine, Double-Blind Method, Drug Therapy, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Humans, International journal of antimicrobial agents, Legionella pneumophila, Llorens Lily, Macrolide, Macrolides/adverse effects/*therapeutic use, Male, Middle Aged, Mycoplasma, Mycoplasma pneumoniae, NEOMED College of Medicine, Phase III as Topic, Pneumonia, Randomized Controlled Trials as Topic, Talbot George H, Time Factors, Treatment Outcome
Prediction of cardiac death in patients with a very low ejection fraction after myocardial infarction: a Cardiac Arrhythmia Suppression Trial (CAST) study.
Tags: *Stroke Volume, 1995, American heart journal, Anderson J, Blood Pressure, Chahine R A, Department of Internal Medicine, Hallstrom A, Heart Arrest/mortality, Heart Rate, Humans, Josephson R A, Left/*mortality/physiopathology, Morganroth J, Multicenter Studies as Topic, Myocardial Infarction/drug therapy/*mortality/physiopathology, NEOMED College of Medicine, Prognosis, Proportional Hazards Models, Randomized Controlled Trials as Topic, Risk Factors, Thrombolytic Therapy, Ventricular Dysfunction, Waldo A